This site is intended for healthcare professionals

ENVISION Phase III study results of Givlaari to treat acute hepatic porphyria were published online in the NEJM.- Alnylam Pharma

Read time: 1 mins
Last updated:16th Mar 2021
Published:12th Jun 2020
Condition: Porphyria
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest